JPY 610.0
(-0.65%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 4.4 Million JPY | 38.64% |
2022 | 3.17 Million JPY | -3.32% |
2021 | 3.28 Million JPY | 71.64% |
2020 | 1.91 Million JPY | 91.5% |
2019 | 1 Million JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 4.38 Million JPY | -0.43% |
2023 Q2 | 3.06 Million JPY | 2.75% |
2023 Q4 | 4.4 Million JPY | 47.26% |
2023 Q3 | 2.99 Million JPY | -2.32% |
2023 FY | 4.4 Million JPY | 38.64% |
2023 Q1 | 2.98 Million JPY | -6.2% |
2022 Q3 | 8 Million JPY | 141.62% |
2022 FY | 3.17 Million JPY | -3.32% |
2022 Q4 | 3.17 Million JPY | -60.28% |
2022 Q2 | 3.31 Million JPY | 0.0% |
2021 FY | 3.28 Million JPY | 71.64% |
2020 FY | 1.91 Million JPY | 91.5% |
2019 FY | - JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Kyowa Kirin Co., Ltd. | 71.36 Billion JPY | 99.994% |
Astellas Pharma Inc. | 248.73 Billion JPY | 99.998% |
Chugai Pharmaceutical Co., Ltd. | 273.48 Billion JPY | 99.998% |
Ono Pharmaceutical Co., Ltd. | 48.62 Billion JPY | 99.991% |
Santen Pharmaceutical Co., Ltd. | 43.18 Billion JPY | 99.99% |
JCR Pharmaceuticals Co., Ltd. | 20.93 Billion JPY | 99.979% |
Daiichi Sankyo Company, Limited | 438.11 Billion JPY | 99.999% |
Otsuka Holdings Co., Ltd. | 249.58 Billion JPY | 99.998% |